The retrospective patient chart review aims to generate additional data to substantiate the safety and performance of EndoGYNious and PelviGYNious.

Inclusion Criteria:

• Surgery for POP
• Implantation of either EndoGYNious or PelviGYNious
• Concomitant procedures are allowed
• Women minimum 18 years old
• Written informed consent for surgery

Exclusion Criteria:

Patients who rule out subsequent contact by the hospital will be excluded.

The use of the products is contraindicated in case of:

• pregnancy and/or patients who consider future pregnancies
• adolescent/ pubescent patients
• existence of a known sensitivity/ allergy against plastic materials such as polypropylene, polyester, etc.
• any pathology, including known or suspected uterine pathology, which would compromise placement of the implant/mesh (e.g. anatomical distortion or abnormalities)
• known anticoagulation disorder
• anticoagulant therapy
• autoimmune connective tissue disease
• renal insufficiency and upper urinary tract obstruction
• cancer illnesses of the vagina / cervix / rectum
• undergone radiation therapy on the vagina, cervix, rectum
• planned or emergency opening of the gastro-intestinal tract, as this could cause a risk of product contamination that could lead to infection that would require removal of the implant/device
• active or latent infection especially of the genital system and/or urinary tract

The planned clinical investigation is a retrospective chart review of clinical data.

All patients who underwent surgery between January 2016 and December 2023 and met the inclusion criteria and no exclusion criteria were analyzed.